D. Deb

Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes

Anindita Das, M. Scian, K. Stagliano, 2004, Oncogene.

Disruption of functions of wild-type p53 by hetero-oligomerization.

D. Troyer, S. Deb, D. Deb, 1999, International journal of oncology.

Hetero-oligomerization does not compromise ‘gain of function’ of tumor-derived p53 mutants

M. Scian, S. Deb, S. Deb, 2002, Oncogene.

`Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domain

S. Deb, J. Ludes-Meyers, M. Subler, 1998, Oncogene.

Wild-type p53 and p73 negatively regulate expression of proliferation related genes

M. Anderson, M. Scian, K. Stagliano, 2008, Oncogene.

The human oncoprotein MDM2 uses distinct strategies to inhibit transcriptional activation mediated by the wild-type p53 and its tumor-derived mutants.

S. Deb, S. Deb, R. Muñoz, 2001, International journal of oncology.

Differential modulation of cellular and viral promoters by p73 and p53.

M. Scian, S. Deb, S. Deb, 2001, International journal of oncology.